Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death-Ligand 1.
Ontology highlight
ABSTRACT: We demonstrated previously that mouse hepatic stellate cells (HSCs) suppress T cells via programmed death-ligand 1 (PD-L1), but it remains unknown whether they exert any effects on B cells, the other component of the adaptive immune system. In this study, we found that mouse HSCs directly inhibited B cells and that PD-L1 was also integrally involved. We found that HSCs inhibited the upregulation of activation markers on activated B cells, as well as the proliferation of activated B cells and their cytokine/Ig production in vitro, and that pharmaceutically or genetically blocking the interaction of PD-L1 with programmed cell death protein 1 impaired the ability of HSCs to inhibit B cells. To test the newly discovered B cell-inhibitory activity of HSCs in vivo, we developed a protocol of int
SUBMITTER: Li Y
PROVIDER: S-EPMC4784705 | biostudies-literature | 2016 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA